title: Targeting innate immunity in type 1 diabetes: strike one.
authors.affiliation: Deutsche Forschungsgemeinschaft, Center for Regenerative Therapies and Paul Langerhans Institute Dresden-German Center for Diabetes Research (DZD), Technische Universität Dresden, 01307 Dresden, Germany. ezio.bonifacio@crt-dresden.de
authors.forename: Ezio
authors.initials: E
authors.lastname: Bonifacio
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007155:Immunologic Factors / Q000627:therapeutic use*; D053590:Interleukin 1 Receptor Antagonist Protein / Q000627:therapeutic use*; D008297:Male
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007004:Hypoglycemic Agents; D007155:Immunologic Factors; D053590:Interleukin 1 Receptor Antagonist Protein; C541220:canakinumab